Size Matters: Sequential Mutations in Tumorigenesis May Reflect the Stochastic Effect of Mutagen Target Sizes

Abstract

We tallied the number of possible mutant amino acids in proteins thought to be inactivated early in tumorigenesis and in proteins thought to be inactivated late in tumorigenesis, respectively. Proteins thought to be inactivated early in tumorigenesis, on average, have a greater number of alternative, mutant possibilities, which raises the possibility that the sequential order of mutations associated with cancer development reflects the random chance, throughout life, of a mutagen inactivating a larger versus a smaller target. The hypothesis that the temporal order of genetic changes in cancer reflects mutagen target sizes leads to novel considerations of 1) the mechanisms of the acquisition of cancer hallmarks and 2) cancer screening strategies. Keywordssequential cancer mutations, tumor suppressor proteins, metastasis suppressor proteins Review

Identification of Sets of Cytoskeletal Related and Adhesion-related Coding Region Mutations in the TCGA Melanoma Dataset that Correlate with a Negative Outcome

“…However, there is little biochemical, mechanistic distinction between classical tumor suppressor and metastasis suppressor proteins [3], and thus, for the purpose of applying the functional degeneracy principle, the tumor suppressor set used here includes both types of coding regions. (For further details on the establishment of the above, five coding regions sets, see Methods .…”

Modeling of Cancer Classifier to Predict Site of Origin

“…Gene size matters for cancer disease as abnormal cells multiply [54], [55]; which is reflected by size of Nyquist curve. According to the shape of curve, the cancerous genes are divided into two groups i.e.…”

TCGA: Increased oncoprotein coding region mutations correlate with a greater expression of apoptosis-effector genes and a positive outcome for stomach adenocarcinoma

“…The oncoprotein and tumor suppressor sets have been previously described. 31,35,36 Barcodes having 4 or more oncoprotein coding region mutations were considered to be high oncoprotein coding region mutation barcodes and served as the experimental group. Barcodes having no known oncoprotein coding region mutations, based on the above referenced oncoprotein set, were sorted randomly using a random number generator function and grouped into 3 sets (SET 1-3) to serve as control groups ("SOM STAD, apoptosis").…”

“…The chromosome number, start position, reference allele and tumor sequence allele data were collected for the oncoprotein and tumor suppressor coding region sets 31,35,36 for each clinical outcome group. The data was then copied into PROVEAN under the "Human Genome Variants" protocol.…”